Skip to content
WeighLab

LumiMeds vs myRocky

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

LumiMeds

Provider comparison

Shoppers willing to commit to a fixed plan term to get the lowest advertised rate, and who value a named, board-certified medical director.

Semaglutide / month
$89/moAs low as, fixed-term plan, plan length not stated, compounded; first month as low as $39
Tirzepatide / month
$125/moAs low as, fixed-term plan, plan length not stated, compounded; first month as low as $75
Index 57/100 · Grade CChecked October 2026

myRocky

Provider comparison

Readers seeking branded medication who will verify their state, dispensing details, supply length and all program charges before paying.

Semaglutide / month
Monthly medication cost not established (Ozempic listed $1,409; compounded offer $397, supply to confirm; plus $99/mo program fee)
Tirzepatide / month
Monthly medication cost not established (Mounjaro listed $1,509; supply to confirm; plus $99/mo program fee)
Index 57/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Both score 57/100 on the Cost-Efficiency Index. There is no score winner; compare the treatment you need, billing terms and state availability.

Check the difference in state access

LumiMeds
Coverage not published
myRocky
Treatment-specific eligibility to confirm; coverage page lists 42 states

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

LumiMeds

myRocky

Semaglutide / month
LumiMeds: $89/moAs low as, fixed-term plan, plan length not stated, compounded; first month as low as $39
myRocky: Monthly medication cost not established (Ozempic listed $1,409; compounded offer $397, supply to confirm; plus $99/mo program fee)
Tirzepatide / month
LumiMeds: $125/moAs low as, fixed-term plan, plan length not stated, compounded; first month as low as $75
myRocky: Monthly medication cost not established (Mounjaro listed $1,509; supply to confirm; plus $99/mo program fee)
Semaglutide / year (modeled)
LumiMeds: $1,068
myRocky: —
Tirzepatide / year (modeled)
LumiMeds: $1,500
myRocky: —
State availability
LumiMeds: Coverage not published
myRocky: Treatment-specific eligibility to confirm; coverage page lists 42 states
Oral / sublingual option listed
LumiMeds: Not listed
myRocky: Yes
Brand-name access listed
LumiMeds: Not confirmed
myRocky: Yes
Provider facts checked
LumiMeds: October 2026
myRocky: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

LumiMeds

Shoppers willing to commit to a fixed plan term to get the lowest advertised rate, and who value a named, board-certified medical director.

Reasons to consider it

  • Named, credentialed Medical Director (Dr. Teresa Walsh, M.D., board certified in obesity medicine) rather than an anonymous 'board-certified physicians' claim
  • LegitScript Certified and HIPAA compliant
  • Full refund if a provider decides treatment isn't right for you

What to weigh up

  • Every plan is a fixed-term commitment: its terms make plans non-cancelable and non-refundable once started, and canceling for any reason other than a prescription denial costs a $100 fee
  • Both headline prices are 'as low as' figures, the product cards lead with first-month prices ($39 and $75), and the site doesn't say what the plain month-to-month rate is
  • Ships compounded medication to 'most U.S. states', with your state confirmed during the consultation

Regulatory note: the FDA issued a warning letter to Lumimeds in September 2025. We still list and link to LumiMeds; you should know the letter is on the public record before you decide.

myRocky

Readers seeking branded medication who will verify their state, dispensing details, supply length and all program charges before paying.

Reasons to consider it

  • Names its pharmacy and clinical leadership
  • Lists Ozempic, Wegovy, Mounjaro and oral Rybelsus
  • Separately displays a compounded semaglutide offer

What to weigh up

  • Medication listing prices do not identify a monthly supply length; do not compare them as monthly treatment costs
  • The $99 monthly program charge is additional to medication
  • Coverage varies by service, and older legal and current coverage lists differ; confirm the weight-loss service in your state

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

LumiMedsmyRocky
Normalized Cost/Month
LumiMeds:
70/100
myRocky:
45/100
Price Transparency
LumiMeds:
78/100
myRocky:
78/100
Nationwide Access
LumiMeds:
24/100
myRocky:
24/100
Formulation Options
LumiMeds:
66/100
myRocky:
90/100
Clinical Oversight
LumiMeds:
70/100
myRocky:
78/100
Contract Flexibility
LumiMeds:
20/100
myRocky:
35/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.